Children's Precision Medicine

Current Projects

Baltimore have partnered to form a one-stop-shop for pediatric drug and device development. The Initiative for Pediatric Drug and Device Development (iPD3) is a first-in-kind venture uniting leaders in pediatrics and pediatric pharmacology aimed at filling critical unmet needs in advancing the pediatric therapeutics landscape. iPD3 will work with pharmaceutical companies and other clients from inception to regulatory filing, including the conduct of pediatric clinical trials.